Zobrazeno 1 - 10
of 502
pro vyhledávání: '"Te-Chun Hsia"'
Autor:
Hsu-Yuan Chen, Chia-Hung Chen, Wei-Chih Liao, Yu-Chao Lin, Hung-Jen Chen, Te-Chun Hsia, Wen-Chien Cheng, Chih-Yen Tu
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Osimertinib is an irreversible third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). It is the preferred first-line treatment for EGFR-mutated non-small cell lung cancer (NSCLC) compared to firs
Externí odkaz:
https://doaj.org/article/6c9feeed91984718bc84979f42eb8c99
Autor:
Hung‐Jen Chen, Wen‐Chien Cheng, Chih‐Yen Tu, Te‐Chun Hsia, Yu‐Sen Lin, Hsin‐Yuan Fang, Chia‐Chin Li, Chun‐Ru Chien
Publikováno v:
Thoracic Cancer, Vol 15, Iss 24, Pp 1779-1791 (2024)
Abstract Introduction The use of stereotactic ablative radiotherapy (SABR) over conventional fractionated radiotherapy (CFRT) for early‐stage non‐small‐cell lung cancer (NSCLC) has been advocated, but is also debated in the literature. Methods
Externí odkaz:
https://doaj.org/article/b5a1df5980e245789315c493f66a336b
Autor:
Bin-Chi Liao, Nai-Jung Chiang, Gee-Chen Chang, Wu-Chou Su, Yung-Hung Luo, Inn-Wen Chong, Tsung-Ying Yang, Chun-Liang Lai, Te-Chun Hsia, Ching-Liang Ho, Kang-Yun Lee, Chin-Fu Hsiao, Fan-Chen Ku, Wei-Tse Fang, James Chih-Hsin Yang
Publikováno v:
JCO Global Oncology, Iss 10 (2024)
PURPOSETissue-based next-generation sequencing (NGS) analysis is highly recommended for patients with advanced/metastatic non–small cell lung cancer (NSCLC). We investigated a specific patient population with NSCLC that required tissue-based NGS an
Externí odkaz:
https://doaj.org/article/e503bb76a5e74e31a0d489729debaa21
Autor:
Yen-Sung Lin, Te-Chun Shen, Cheng-Li Lin, Chih-Yen Tu, Te-Chun Hsia, Wu-Huei Hsu, Der-Yang Cho
Publikováno v:
Journal of Epidemiology and Global Health, Vol 14, Iss 3, Pp 860-868 (2024)
Abstract Background Pneumoconiosis is associated with pulmonary and cardiovascular diseases; however, the link between pneumoconiosis and sleep disorders is not well understood. This study aimed to investigate the connection between pneumoconiosis an
Externí odkaz:
https://doaj.org/article/1f64a9a36b76404e86714dc13bfe6f48
Autor:
Wen-Chien Cheng, Chi-Chien Lin, Wei-Chih Liao, Yu-Chao Lin, Chia-Hung Chen, Hung-Jen Chen, Chih-Yen Tu, Te-Chun Hsia
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Objectives The irreversible epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) afatinib and dacomitinib are approved for first-line treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC). We aimed to comp
Externí odkaz:
https://doaj.org/article/d39ef3124fc64d44bd1141cb823d8225
Autor:
Wei‐Chun Chen, Wen‐Chien Cheng, Chieh‐Lung Chen, Wei‐Chih Liao, Chia‐Hung Chen, Hung‐Jen Chen, Chih‐Yen Tu, Chi‐Chen Lin, Te‐Chun Hsia
Publikováno v:
Cancer Medicine, Vol 13, Iss 7, Pp n/a-n/a (2024)
Abstract Background This study aimed to examine the clinical characteristics of bone metastasis (BoM) in patients with non‐small cell lung cancer (NSCLC) who have an epidermal growth factor receptor (EGFR) mutation and to identify the most effectiv
Externí odkaz:
https://doaj.org/article/bb2d95e0862942759be2f35dbd3c2237
Autor:
Chieh-Lung Chen, Sing-Ting Wang, Wei-Chih Liao, Chia-Hung Chen, Chih-Yen Tu, Te-Chun Hsia, Wen-Chien Cheng, Hung-Jen Chen
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background The patient population with stage III non-small-cell lung cancer (NSCLC) is heterogeneous, with varying staging characteristics and diverse treatment options. Despite the potential practice-changing implications of randomized cont
Externí odkaz:
https://doaj.org/article/e3287c0494444d8d86120f3fa55815dc
Autor:
Gee-Chen Chang, Jin-Yuan Shih, Chong-Jen Yu, Heng-Sheng Chao, Cheng-Ta Yang, Chien-Chung Lin, Jen-Yu Hung, Sheng-Yen Hsiao, Chin-Chou Wang, Chih-Feng Chian, Te-Chun Hsia, Yuh-Min Chen
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0303046 (2024)
Osimertinib has demonstrated efficacy in patients with epidermal growth factor receptor (EGFR) T790M-positive non-small cell lung cancer (NSCLC) in clinical trials. However, real-world data on its effectiveness remain scarce. Taiwanese patients with
Externí odkaz:
https://doaj.org/article/91e401521dec4d66b6ca2b8d34fd01f0
Publikováno v:
Canadian Respiratory Journal, Vol 2024 (2024)
Background. The effectiveness of definitive radiotherapy (RT) for patients with clinical stage IIIB or IIIC lung adenocarcinoma and epidermal growth factor receptor (EGFR) mutations who received first- or second-generation EGFR tyrosine kinase inhibi
Externí odkaz:
https://doaj.org/article/c13550cd03a8452298fbb8974c8a3f6b
Autor:
Bing-Qi Wu, De-Yi Liu, Te-Chun Shen, Yu-Ru Lai, Tsai-Ling Yu, Hsiang-Li Hsu, Hsiu-Ming Lee, Wei-Chih Liao, Te-Chun Hsia
Publikováno v:
Life, Vol 14, Iss 4, p 438 (2024)
The coronavirus disease (COVID-19) pandemic has resulted in an increasing population that is experiencing a wide range of long-lasting symptoms after recovery from the acute infection. Long COVID refers to this specific condition and is associated wi
Externí odkaz:
https://doaj.org/article/01599ae80c524b399724c2a34402dc9f